stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Pharmacosmos A/S

Denmark · Privately owned

Pharmacosmos makes and sells iron-based medicines to treat anemia and iron deficiency around the world.

Pharmacosmos is a Danish drug company that treats one of the most common health problems on the planet: too little iron in the body. When people don't have enough iron, they can't make enough healthy red blood cells, and that leads to iron deficiency and anemia — leaving them tired, weak, and short of breath. Pharmacosmos sells treatments that fix this, both as pills patients take at home and as intravenous iron that nurses give in a clinic when pills aren't enough or the gut can't absorb iron well.

The business has two kinds of customers. It sells oral iron products, largely over the counter, to pharmacies and consumers, and it sells prescription IV iron to hospitals, clinics, and doctors who treat patients with serious deficiency — think kidney disease, heavy periods, pregnancy, and chronic illness. The company also supplies a key raw material, iron carbohydrate, to other drugmakers, which quietly makes it an important link in the wider iron-medicine supply chain. The core brand most people would recognize is its oral iron line, sold widely in pharmacies. What makes Pharmacosmos interesting is that it is a family-controlled private company based in Holbæk, Denmark, and it has stayed focused on iron for decades rather than chasing blockbuster drugs. That focus lets it own deep know-how in the chemistry of getting iron into the body safely, which is harder than it sounds — too much free iron is toxic, so the formulation work matters. Its main competition comes from big IV-iron players and generic pill makers, and the IV market in particular is crowded.


The company ploughs its profits back into manufacturing and product development rather than paying public shareholders, since there are none. It has expanded its reach into major markets including the United States, where IV iron is a growing business as doctors look for faster fixes than months of tablets. For a private Danish firm, it punches well above its weight in a niche that touches millions of patients every year.

Saved answer · last researched 15 Nov 2026